| # | Drug | Count |
|---|---|---|
| 0 | TAMOXIFEN CITRATE | 15 |
| 1 | LEVONORGESTREL | 12 |
| 2 | MEDROXYPROGESTERONE ACETATE | 8 |
| 3 | CONJUGATED ESTROGENS | 7 |
| 4 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 7 |
| 5 | ESTRADIOL | 7 |
| 6 | ESTROGENS, CONJUGATED | 7 |
| 7 | ADALIMUMAB | 6 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 6 |
| 9 | VENLAFAXINE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPHEDRINE HYDROCHLORIDE | 2 | 0.0044 |
| 1 | TAMOXIFEN CITRATE | 15 | 0.0026 |
| 2 | ESTRADIOL VALERATE | 1 | 0.0013 |
| 3 | ADALIMUMAB-RYVK | 1 | 0.0009 |
| 4 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 2 | 0.0007 |
| 5 | ESTROGEN | 1 | 0.0003 |
| 6 | CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE | 7 | 0.0003 |
| 7 | ETONOGESTREL AND ETHINYL ESTRADIOL | 6 | 0.0003 |
| 8 | MIFEPRISTONE | 1 | 0.0002 |
| 9 | CABERGOLINE | 1 | 0.0002 |
| # | Drug class | Count |
|---|---|---|
| 0 | Progestin [EPC] | 18 |
| 1 | Estrogen [EPC] | 16 |
| 2 | Progestin-containing Intrauterine System [EPC] | 12 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 4 | Corticosteroid [EPC] | 7 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 5 |
| 6 | Vitamin D [EPC] | 4 |
| 7 | Benzodiazepine [EPC] | 3 |
| 8 | Insulin Analog [EPC] | 3 |
| 9 | Interleukin-23 Antagonist [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Progestin Antagonist [EPC] | 1 | 0.0002 |
| 1 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 3 | Estrogen [EPC] | 16 | 0.0001 |
| 4 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 5 | Sympathomimetic-like Agent [EPC] | 2 | 0.0001 |
| 6 | Progestin [EPC] | 18 | 0.0001 |
| 7 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 8 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 9 | General Anesthetic [EPC] | 2 | 0.0000 |